Anfield Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.18K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $1.2M | Hold |
|
|||||
|
2024
Q3 | $1.38M | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $1.08M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $916K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $154K | Sell |
|
|||||
|
2022
Q3 | $360K | Buy |
|
|||||
|
2022
Q2 | $338K | Buy |
|
|||||
|
2022
Q1 | $268K | Buy |
|
|||||
|
2021
Q4 | $97K | Buy |
|
|||||
|
2021
Q3 | $7K | Buy |
|